0.344
5.74%
-0.0209
시간 외 거래:
.34
-0.004
-1.16%
Aptose Biosciences Inc (APTO) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
19.52%
9.76
|
12.13 | 11.68 | 14.45 | 14.10 |
Nonoperating Income/Loss |
30.23%
0.12
|
0.172 | 0.234 | 0.323 | 0.42 |
Income/Loss From Continuing Operations Before Tax |
104.18%
0.50
|
-11.96 | -11.45 | -14.13 | -13.68 |
Income/Loss From Continuing Operations After Tax |
104.18%
0.50
|
-11.96 | -11.45 | -14.13 | -13.68 |
Net Income/Loss
|
19.36%
-9.64
|
-11.96 | -11.45 | -14.13 | -13.68 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
3,508%
13.13
|
0.364 | 6.495 | 6.234 | 92.56 |
Diluted Average Shares |
3,508%
13.13
|
0.364 | 6.495 | 6.234 | 92.56 |
Basic Earnings Per Share |
53.50%
-0.73
|
-1.57 | -1.76 | -2.27 | -2.25 |
Diluted Earnings Per Share |
53.50%
-0.73
|
-1.57 | -1.76 | -2.27 | -2.25 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):